Drug-coated stents not as risky as thought, doctors say

11/11/2007 | NYTimes.com

Some doctors now prefer to use drug-coated stents over other treatment options for diseased coronary arteries, thanks to recent studies proving the devices' effectiveness, particularly among patients with severe heart conditions. Last year, many specialists refrained from using drug-coated stents after clinical trials showed increased risk of fatal blood clotting. However, a recent study of 17,000 stent recipients reported a 9.4% death rate among drug-coated stent patients, compared with 11.9% of those who got bare-metal stents.

View Full Article in:

NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Payer Marketing
Avalere Health
Washington, DC
Chief Quality Officer
UnityPoint Clinic
Des Moines, ID
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX
The Pew Charitable Trusts
Director, Antibiotics and Innovation Project
Washington, DC
Senior Officer, Drugs and Medical Devices
The Pew Charitable Trusts
Washington, DC